rs116139984

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001692.4(ATP6V1B1):​c.654C>T​(p.Asp218Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00546 in 1,602,596 control chromosomes in the GnomAD database, including 381 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.027 ( 190 hom., cov: 31)
Exomes 𝑓: 0.0032 ( 191 hom. )

Consequence

ATP6V1B1
NM_001692.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -3.45

Publications

2 publications found
Variant links:
Genes affected
ATP6V1B1 (HGNC:853): (ATPase H+ transporting V1 subunit B1) This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c'', and d. Additional isoforms of many of the V1 and V0 subunit proteins are encoded by multiple genes or alternatively spliced transcript variants. This encoded protein is one of two V1 domain B subunit isoforms and is found in the kidney. Mutations in this gene cause distal renal tubular acidosis associated with sensorineural deafness. [provided by RefSeq, Jul 2008]
VAX2 (HGNC:12661): (ventral anterior homeobox 2) This gene encodes a homeobox protein and is almost exclusively expressed in the ventral portion of the retina during development. In mouse studies, this gene was found to be required for the correct formation of the optic fissure and other aspects of retinal development. [provided by RefSeq, Sep 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 2-70960989-C-T is Benign according to our data. Variant chr2-70960989-C-T is described in ClinVar as Benign. ClinVar VariationId is 44230.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.45 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0932 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP6V1B1NM_001692.4 linkc.654C>T p.Asp218Asp synonymous_variant Exon 7 of 14 ENST00000234396.10 NP_001683.2
ATP6V1B1XM_011532907.3 linkc.774C>T p.Asp258Asp synonymous_variant Exon 6 of 13 XP_011531209.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP6V1B1ENST00000234396.10 linkc.654C>T p.Asp218Asp synonymous_variant Exon 7 of 14 1 NM_001692.4 ENSP00000234396.4
ENSG00000258881ENST00000606025.5 linkc.476-18556G>A intron_variant Intron 5 of 5 5 ENSP00000475641.1

Frequencies

GnomAD3 genomes
AF:
0.0272
AC:
4146
AN:
152232
Hom.:
187
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0954
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00830
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.000367
Gnomad OTH
AF:
0.0181
GnomAD2 exomes
AF:
0.00692
AC:
1589
AN:
229678
AF XY:
0.00519
show subpopulations
Gnomad AFR exome
AF:
0.101
Gnomad AMR exome
AF:
0.00332
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000589
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000341
Gnomad OTH exome
AF:
0.00298
GnomAD4 exome
AF:
0.00316
AC:
4586
AN:
1450246
Hom.:
191
Cov.:
31
AF XY:
0.00271
AC XY:
1955
AN XY:
720222
show subpopulations
African (AFR)
AF:
0.105
AC:
3489
AN:
33144
American (AMR)
AF:
0.00374
AC:
162
AN:
43268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25904
East Asian (EAS)
AF:
0.0000256
AC:
1
AN:
39086
South Asian (SAS)
AF:
0.000274
AC:
23
AN:
84018
European-Finnish (FIN)
AF:
0.0000382
AC:
2
AN:
52416
Middle Eastern (MID)
AF:
0.00607
AC:
35
AN:
5762
European-Non Finnish (NFE)
AF:
0.000434
AC:
480
AN:
1106740
Other (OTH)
AF:
0.00658
AC:
394
AN:
59908
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
257
513
770
1026
1283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0273
AC:
4166
AN:
152350
Hom.:
190
Cov.:
31
AF XY:
0.0269
AC XY:
2004
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0956
AC:
3975
AN:
41562
American (AMR)
AF:
0.00823
AC:
126
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.000367
AC:
25
AN:
68038
Other (OTH)
AF:
0.0180
AC:
38
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
199
398
598
797
996
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0127
Hom.:
53
Bravo
AF:
0.0311
Asia WGS
AF:
0.00520
AC:
18
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Renal tubular acidosis with progressive nerve deafness Benign:3
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 06, 2017
Counsyl
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:2
Jan 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Asp218Asp in Exon 07 of ATP6V1B1: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wi thin the splice consensus sequence, and has been identified in 9.1% (339/3736) o f African American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs116139984). -

not provided Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
0.13
DANN
Benign
0.89
PhyloP100
-3.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116139984; hg19: chr2-71188119; API